Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Nycomed: Q1 1997 highlights

June 9, 1997

Promising data with Parkinson's disease diagnostic reported

June 9, 1997

First approval for new MRI contrast agent from Nycomed

June 6, 1997

Update on Immunomedics diagnostic imaging products

June 6, 1997

Diatide's P829 reliably excludes malignancy in patients with SPN

June 5, 1997

New MRI contrast agent from Nycomed

June 4, 1997

Scios licenses BNP technology to Abbott

June 4, 1997

NIH funds development of Glyko Biomedical's lysosomal storage disease test

June 3, 1997

Metra Biosystems' bone resorption immunoassay cleared in Japan

June 3, 1997

Mallinckrodt describes new imaging agents

June 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...